The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. The gene therapy biotech company ...
News
- Vascular Biogenics: Q1 Earnings Snapshot
- FibroGen: Q1 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share. The biotech drug developer ...
- Six Ways to Get Your Mind "Unstuck" While Your Body May be Stuck at Home
... University of Texas Health at San Antonio and in public health and health sciences at Los Angeles Pacific University. He holds a Ph.D. in biomedical sciences and medical physiology and an MPH in chronic disease epidemiology.
- Cara: Q1 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share. The biotechnology company posted ...
- Scholarship student giving college savings away to help others reach education goals
"I plan to go to Southeast Missouri State and go into their pre-optometry program," Nelson said. "I'll be majoring in bio-medical sciences." What Josh didn ...